FRMM (FRMM) Set to Report Q2 Earnings on July 22, 2026
Earnings Results FRMM (NASDAQ:FRMM) is scheduled to report its Q2 earnings results on July 22, 2026 after market close. Analysts expect the company to report earnings per share of…
Read moreReal-time context
Follow the latest analyst actions, insider and institutional activity, earnings, dividends, price moves, and company filings.
Earnings Results FRMM (NASDAQ:FRMM) is scheduled to report its Q2 earnings results on July 22, 2026 after market close. Analysts expect the company to report earnings per share of…
Read moreEarnings Results ARMOUR Residential REIT, Inc. (NYSE:ARR) is scheduled to report its Q2 earnings results on July 22, 2026 after market close. Analysts expect the Real Estate…
Read moreEarnings Results Core Laboratories N.V. (NYSE:CLB) is scheduled to report its Q2 earnings results on July 22, 2026 after market close. Analysts expect the Energy company to report…
Read moreEarnings Results Annaly Capital Management, Inc. (NYSE:NLY) is scheduled to report its Q2 earnings results on July 22, 2026 after market close. Analysts expect the Real Estate…
Read moreEarnings Results Oatly Group AB (NASDAQ:OTLY) is scheduled to report its Q2 earnings results on July 22, 2026 after market close. Analysts expect the Consumer Defensive company to…
Read moreEarnings Results TE Connectivity Ltd. (NYSE:TEL) is scheduled to report its Q3 earnings results on July 22, 2026 after market close. Analysts expect the Technology company to…
Read moreRating Change Rodman & Renshaw analysts initiated coverage on Eledon Pharmaceuticals, Inc. (NASDAQ:ELDN) with a Buy rating on July 21, 2026. Market Context Eledon Pharmaceuticals,…
Read moreRating Change Barclays analysts initiated coverage on Forte Biosciences, Inc. (NASDAQ:FBRX) with a Overweight rating on July 21, 2026. Market Context Forte Biosciences, Inc.
Read moreRating Change Needham analysts reiterated a Buy rating on Park Aerospace Corp. (NYSE:PKE) on July 21, 2026. Market Context Park Aerospace Corp.
Read moreRating Change Northland Capital Markets analysts initiated coverage on Inflection Point Acquisition Corp. IV Unit (NASDAQ:BACQU) with a Outperform rating on July 21, 2026. Market…
Read moreRating Change Citizens analysts initiated coverage on Annexon, Inc. (NASDAQ:ANNX) with a Market Underperform rating on July 21, 2026. Market Context Annexon, Inc.
Read moreRating Change Barclays analysts reiterated a Equal-Weight rating on WhiteFiber, Inc. Ordinary Shares (NASDAQ:WYFI) on July 21, 2026. Market Context WhiteFiber, Inc.
Read moreRating Change Canaccord Genuity analysts reiterated a Hold rating on HealthStream, Inc. (NASDAQ:HSTM) on July 21, 2026. Market Context HealthStream, Inc.
Read moreRating Change Morgan Stanley analysts downgraded PagerDuty, Inc. (NYSE:PD) from Equal-Weight to Underweight on July 21, 2026. Market Context PagerDuty, Inc.
Read moreRating Change Jefferies analysts upgraded AdaptHealth Corp. (NASDAQ:AHCO) from Hold to Buy on July 21, 2026. Market Context AdaptHealth Corp.
Read moreRating Change Oppenheimer analysts initiated coverage on KESTRA MEDICAL TECHNOLOGIES, LTD. (NASDAQ:KMTS) with a Perform rating on July 21, 2026. Market Context KESTRA MEDICAL…
Read moreRating Change Barclays analysts reiterated a Underweight rating on Pebblebrook Hotel Trust (NYSE:PEB) on July 21, 2026. Market Context Pebblebrook Hotel Trust operates in the Real…
Read moreRating Change BTIG analysts reiterated a Buy rating on Harrow Health, Inc. 11.875% Senior Notes due 2027 (NASDAQ:HROWM) on July 21, 2026. Market Context Harrow Health, Inc.
Read moreRating Change Goldman Sachs analysts reiterated a Buy rating on Relay Therapeutics, Inc. (NASDAQ:RLAY) on July 21, 2026. Market Context Relay Therapeutics, Inc.
Read moreRating Change Canaccord Genuity analysts reiterated a Buy rating on Teladoc Health, Inc. (NYSE:TDOC) on July 21, 2026. Market Context Teladoc Health, Inc.
Read more